These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35151767)

  • 1. Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice.
    Islam MN; Zhang W; Sakai K; Nakazato Y; Tanida R; Sakoda H; Takei T; Takao T; Nakazato M
    Peptides; 2022 May; 151():170763. PubMed ID: 35151767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
    Shankar K; Metzger NP; Singh O; Mani BK; Osborne-Lawrence S; Varshney S; Gupta D; Ogden SB; Takemi S; Richard CP; Nandy K; Liu C; Zigman JM
    Mol Metab; 2021 Nov; 53():101327. PubMed ID: 34428557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model.
    Cornejo MP; Castrogiovanni D; Schiöth HB; Reynaldo M; Marie J; Fehrentz JA; Perello M
    J Neuroendocrinol; 2019 Oct; 31(10):e12785. PubMed ID: 31469195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner.
    Fernandez G; Cabral A; De Francesco PN; Uriarte M; Reynaldo M; Castrogiovanni D; Zubiría G; Giovambattista A; Cantel S; Denoyelle S; Fehrentz JA; Tolle V; Schiöth HB; Perello M
    Cell Mol Life Sci; 2022 May; 79(5):277. PubMed ID: 35504998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
    Ge X; Yang H; Bednarek MA; Galon-Tilleman H; Chen P; Chen M; Lichtman JS; Wang Y; Dalmas O; Yin Y; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
    Cell Metab; 2018 Feb; 27(2):461-469.e6. PubMed ID: 29233536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEAP2 reduces postprandial glucose excursions and
    Hagemann CA; Jensen MS; Holm S; Gasbjerg LS; Byberg S; Skov-Jeppesen K; Hartmann B; Holst JJ; Dela F; Vilsbøll T; Christensen MB; Holst B; Knop FK
    Cell Rep Med; 2022 Apr; 3(4):100582. PubMed ID: 35492241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets.
    Bayle M; Péraldi-Roux S; Gautheron G; Cros G; Oiry C; Neasta J
    Fundam Clin Pharmacol; 2022 Apr; 36(2):375-377. PubMed ID: 34449915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans.
    Englund A; Gilliam-Vigh H; Suppli MP; Gasbjerg LS; Vilsbøll T; Knop FK
    Peptides; 2024 Jul; 177():171227. PubMed ID: 38657907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
    Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
    J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight.
    Chu G; Peng H; Yu N; Zhang Y; Lin X; Lu Y
    Front Endocrinol (Lausanne); 2022; 13():932761. PubMed ID: 36387867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GHSR signalling in perinatal phases is involved in liver metabolism at puberty.
    Ferreira-Junior MD; Cavalcante KVN; Xavier CH; Vanzela EC; Boschero AC; Matafome P; Gomes RM
    J Endocrinol; 2024 Oct; 263(1):. PubMed ID: 39045853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
    Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
    Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
    M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
    J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-expressed antimicrobial peptide 2 antagonizes the effect of ghrelin in rodents.
    Islam MN; Mita Y; Maruyama K; Tanida R; Zhang W; Sakoda H; Nakazato M
    J Endocrinol; 2020 Jan; 244(1):13-23. PubMed ID: 31539874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LEAP2 changes with body mass and food intake in humans and mice.
    Mani BK; Puzziferri N; He Z; Rodriguez JA; Osborne-Lawrence S; Metzger NP; Chhina N; Gaylinn B; Thorner MO; Thomas EL; Bell JD; Williams KW; Goldstone AP; Zigman JM
    J Clin Invest; 2019 Sep; 129(9):3909-3923. PubMed ID: 31424424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions.
    Gupta D; Patterson AM; Osborne-Lawrence S; Bookout AL; Varshney S; Shankar K; Singh O; Metzger NP; Richard CP; Wyler SC; Elmquist JK; Zigman JM
    Mol Metab; 2021 Nov; 53():101258. PubMed ID: 34023483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Coexpression of the Ghrelin and LEAP2 Receptor GHSR With Pancreatic Polypeptide in Mouse and Human Islets.
    Gupta D; Dowsett GKC; Mani BK; Shankar K; Osborne-Lawrence S; Metzger NP; Lam BYH; Yeo GSH; Zigman JM
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34289060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice.
    Shankar K; Metzger NP; Lawrence C; Gupta D; Osborne-Lawrence S; Varshney S; Singh O; Richard CP; Zaykov AN; Rolfts R; DuBois BN; Perez-Tilve D; Mani BK; Hammer STG; Zigman JM
    Mol Metab; 2024 Jun; 84():101950. PubMed ID: 38697291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ups and downs of growth hormone secretagogue receptor signaling.
    Cornejo MP; Mustafá ER; Cassano D; Banères JL; Raingo J; Perello M
    FEBS J; 2021 Dec; 288(24):7213-7229. PubMed ID: 33460513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hindbrain ghrelin and liver-expressed antimicrobial peptide 2, ligands for growth hormone secretagogue receptor, bidirectionally control food intake.
    Wald HS; Ghidewon MY; Hayes MR; Grill HJ
    Am J Physiol Regul Integr Comp Physiol; 2023 Apr; 324(4):R547-R555. PubMed ID: 36847494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.